Race-Based Guidance and Nirsevimab

This Viewpoint discusses the current Advisory Committee on Immunization Practices and American Academy of Pediatrics race-based guidelines on the administration of nirsevimab and suggested race-conscious revision of the current guidance.

Authors

Institutions

Publication Details

Journal
JAMA Pediatrics
Published
2025-03-17
DOI
https://doi.org/10.1001/jamapediatrics.2025.0067
Citations
1
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Race-Based Guidance and Nirsevimab

J. Williams, Florence Wu
1 citations
JAMA Pediatrics
Immunodeficiency and Autoimmune Disorders
0.80
article

Race-Based Guidance and Nirsevimab

J. Williams, Florence Wu
article en
1 citations

Abstract

This Viewpoint discusses the current Advisory Committee on Immunization Practices and American Academy of Pediatrics race-based guidelines on the administration of nirsevimab and suggested race-conscious revision of the current guidance.

JAMA PediatricsVol. 179(5)
Denver Health Medical Center (US), University of Colorado Denver (US)
Gender equality
Openalex Percentile: Top 30%
Immunodeficiency and Autoimmune Disorders
0.80
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Race-Based Guidance and Nirsevimab — J. Williams, Florence Wu · JAMA Pediatrics (2025) | TGRS Research Map | TGRS